Search

everythinglearnresearchcommunity

for

Search:↓

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Irish dermatologists use JAK inhibitors for alopecia areata but want standardized treatment guidelines.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Researchers found a new mutation in the FERMT1 gene in a Spanish family with Kindler syndrome.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Promising cancer treatments were found, but the manufacturer closed.

JAK inhibitors do not increase cancer risk in severe alopecia areata compared to traditional treatments.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Keratin K6irs is a marker for the inner root sheath of hair follicles in mice and humans.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Certain drugs increase calcium levels in cancer cells by triggering internal calcium release.

A peptide in shampoo can promote hair growth and improve hair condition.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

CMX from Centipeda minima can significantly improve hair growth in mild to moderate balding.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.